Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367059608> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W4367059608 endingPage "145" @default.
- W4367059608 startingPage "137" @default.
- W4367059608 abstract "Background: Japanese encephalitis (JE) is endemic in various parts of India. Due to the limited treatment options available, a new treatment option that is safe and effective is highly expected for the existing medical needs. Methods: In the present randomized Phase-2/3 study, safety, immunogenicity, and reactogenicity of JE-vaccine manufactured by Biological E (BE-JE), given in 2-dose schedule, 28-days apart was assessed in 456 healthy ≥1 to <3-year-old children compared to a licensed JE-vaccine with 3-dose schedule manufactured by Green-cross-corporation (GCC-JE). Results: The BE-JE group demonstrated non‑inferiority compared to GCC-JE group at day-56 as the lower confidence limit of the group difference was not ≥‑10%. At day-56, the geometric mean titre values were significantly higher in BE-JE group compared with the GCC‑JE group (217.97 vs 125.85; p=0.0023). No apparent difference was seen in the safety-profile between both vaccine groups, with all events reported being either mild or moderate in intensity. Also, no significant difference (p=0.2198) was reported in the number of subjects experiencing at least one adverse-event (AE) between both groups. Conclusions: The present study demonstrated BE‑JE’s Vero-cell‑based inactivated JE-vaccine, administered in 2-dose schedule to be immunogenic, well-tolerated, and non-inferior, compared to GCC‑JE-vaccine, administered in a 3‑dose schedule in the pediatric Indian-population. This study was prospectively registered with clinical trial registry of India bearing no CTRI/2011/091/000108 on 14/02/2011." @default.
- W4367059608 created "2023-04-27" @default.
- W4367059608 creator A5033391594 @default.
- W4367059608 creator A5043558119 @default.
- W4367059608 creator A5044337627 @default.
- W4367059608 creator A5060165103 @default.
- W4367059608 creator A5068298126 @default.
- W4367059608 creator A5073498083 @default.
- W4367059608 creator A5091228492 @default.
- W4367059608 date "2023-04-26" @default.
- W4367059608 modified "2023-10-18" @default.
- W4367059608 title "A multi-center, randomized, controlled, phase-2/3 study to evaluate the safety and immunogenicity of inactivated Japanese encephalitis vaccine in healthy ≥1 to <3 years old Indian children" @default.
- W4367059608 doi "https://doi.org/10.18203/2349-3259.ijct20231104" @default.
- W4367059608 hasPublicationYear "2023" @default.
- W4367059608 type Work @default.
- W4367059608 citedByCount "0" @default.
- W4367059608 crossrefType "journal-article" @default.
- W4367059608 hasAuthorship W4367059608A5033391594 @default.
- W4367059608 hasAuthorship W4367059608A5043558119 @default.
- W4367059608 hasAuthorship W4367059608A5044337627 @default.
- W4367059608 hasAuthorship W4367059608A5060165103 @default.
- W4367059608 hasAuthorship W4367059608A5068298126 @default.
- W4367059608 hasAuthorship W4367059608A5073498083 @default.
- W4367059608 hasAuthorship W4367059608A5091228492 @default.
- W4367059608 hasBestOaLocation W43670596081 @default.
- W4367059608 hasConcept C126322002 @default.
- W4367059608 hasConcept C168563851 @default.
- W4367059608 hasConcept C187212893 @default.
- W4367059608 hasConcept C197934379 @default.
- W4367059608 hasConcept C203014093 @default.
- W4367059608 hasConcept C2522874641 @default.
- W4367059608 hasConcept C2777704310 @default.
- W4367059608 hasConcept C2778540732 @default.
- W4367059608 hasConcept C2779141303 @default.
- W4367059608 hasConcept C2780868878 @default.
- W4367059608 hasConcept C2908647359 @default.
- W4367059608 hasConcept C71924100 @default.
- W4367059608 hasConcept C83455156 @default.
- W4367059608 hasConcept C8891405 @default.
- W4367059608 hasConcept C99454951 @default.
- W4367059608 hasConceptScore W4367059608C126322002 @default.
- W4367059608 hasConceptScore W4367059608C168563851 @default.
- W4367059608 hasConceptScore W4367059608C187212893 @default.
- W4367059608 hasConceptScore W4367059608C197934379 @default.
- W4367059608 hasConceptScore W4367059608C203014093 @default.
- W4367059608 hasConceptScore W4367059608C2522874641 @default.
- W4367059608 hasConceptScore W4367059608C2777704310 @default.
- W4367059608 hasConceptScore W4367059608C2778540732 @default.
- W4367059608 hasConceptScore W4367059608C2779141303 @default.
- W4367059608 hasConceptScore W4367059608C2780868878 @default.
- W4367059608 hasConceptScore W4367059608C2908647359 @default.
- W4367059608 hasConceptScore W4367059608C71924100 @default.
- W4367059608 hasConceptScore W4367059608C83455156 @default.
- W4367059608 hasConceptScore W4367059608C8891405 @default.
- W4367059608 hasConceptScore W4367059608C99454951 @default.
- W4367059608 hasIssue "2" @default.
- W4367059608 hasLocation W43670596081 @default.
- W4367059608 hasOpenAccess W4367059608 @default.
- W4367059608 hasPrimaryLocation W43670596081 @default.
- W4367059608 hasRelatedWork W2087988243 @default.
- W4367059608 hasRelatedWork W2109427852 @default.
- W4367059608 hasRelatedWork W2129429608 @default.
- W4367059608 hasRelatedWork W2140048277 @default.
- W4367059608 hasRelatedWork W2150981177 @default.
- W4367059608 hasRelatedWork W2181441582 @default.
- W4367059608 hasRelatedWork W2185283432 @default.
- W4367059608 hasRelatedWork W2314403824 @default.
- W4367059608 hasRelatedWork W2856535475 @default.
- W4367059608 hasRelatedWork W4301012927 @default.
- W4367059608 hasVolume "10" @default.
- W4367059608 isParatext "false" @default.
- W4367059608 isRetracted "false" @default.
- W4367059608 workType "article" @default.